SAN CARLOS, Calif., May 01, 2006 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) will announce its financial results for the first quarter 2006 on Wednesday, May 10, 2006. On that day, Robert Chess, Nektar chairman of the board and acting president and chief executive officer, will host a conference call for analysts and investors beginning at 2:00 p.m. Pacific Time, to discuss further the Company's performance.
Investors can access a live audio-only webcast through a link that is posted on the Investor Relations section of Nektar's website at http://www.nektar.com. The web broadcast of the conference call will be available for replay through May 24, 2006.
Analysts and investors can also access the conference call live via telephone by dialing (800) 559-2403 (U.S.); (847) 619-6534 (international). The passcode is 14548843 and the host is Mr. Robert Chess. An audio replay will be available shortly following the call through May 24, 2006 and can be accessed by dialing (877) 213-9653 (U.S.); or (630) 652-3041 (international) with a passcode of 14548843. In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.
Nektar Therapeutics develops and enables high-value, differentiated therapeutics with its industry-leading drug delivery technologies, expertise and manufacturing capabilities. The world's top biotechnology and pharmaceutical companies are developing new and better therapeutics using Nektar's advanced technologies and know-how. Nektar also develops its own products by applying its drug delivery technologies and its expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Joyce Strand, 650-631-3138 Jennifer Ruddock, 650-631-4954
Copyright Business Wire 2006
News Provided by COMTEX